Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma.

Autor: Yang, Yu‐Xian1 (AUTHOR), Zheng, Yu‐Zhen2 (AUTHOR), Gao, Tian‐Tian1 (AUTHOR), Liu, Shi‐Liang1 (AUTHOR), Xi, Mian1 (AUTHOR), Liu, Meng‐Zhong1 (AUTHOR), Wang, Jun‐Ye3 (AUTHOR), Qi, Shu‐Nan4 (AUTHOR), Yang, Yong5 (AUTHOR) dr_yangyong1983@163.com, Zhao, Lei1 (AUTHOR) zhaolei@sysucc.org.cn
Zdroj: Cancer Medicine. Oct2022, Vol. 11 Issue 20, p3751-3760. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje